Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription Articles published in PLoS One Retrieve available abstracts of 177 articles: HTML format

Single Articles

January 2025
1. CARRASCO S, Liphaus BL, Peixoto TV, Lima TM, et al
   Early neutrophil activation and NETs release in the pristane-induced lupus mice model.
   PLoS One. 2025;20:e0306943.
   PubMed     Abstract available
   
   
   
2. SIEBALD F, Grittner U, Otto C, Bereuter C, et al
   Ultrasound pupillometry for the detection of a relative afferent pupillary defect (RAPD): Systematic evaluation in patients with optic neuritis and comparison with infrared video pupillometry.
   PLoS One. 2025;20:e0315712.
   PubMed     Abstract available
   
   
   
3. XU Y, Wang Z, Jia T, Liang S, et al
   Exploring potential drug targets for SLE through Mendelian randomization and network pharmacology.
   PLoS One. 2025;20:e0316481.
   PubMed     Abstract available
   
   
   
4. KATZ A, Shulkin A, Fortier MA, Yardley JE, et al
   Strategies to reduce hyperglycemia-related anxiety in elite athletes with type 1 diabetes: A qualitative analysis.
   PLoS One. 2025;20:e0313051.
   PubMed     Abstract available
   
   
   
5. RAO GA, Shoaibi A, Makadia R, Hardin J, et al
   CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterization.
   PLoS One. 2025;20:e0310634.
   PubMed     Abstract available
   
   
   
6. TRAN HT, Rodprasert W, Padeta I, Oontawee S, et al
   Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells.
   PLoS One. 2025;20:e0318204.
   PubMed     Abstract available
   
   
   
7. OROMO DO
   Pediatric Diabetic Ketoacidosis (PDKA) among newly diagnosed diabetic patients at Dilla University Hospital, Dilla, Ethiopia: Prevalence and predictors.
   PLoS One. 2025;20:e0314433.
   PubMed     Abstract available
   
   
   
8. VAN REENEN EC, van Nistelrooij IAM, Visser LH, de Beukelaar JWK, et al
   The liminal space between hope and grief: The phenomenon of uncertainty as experienced by people living with relapsing-remitting multiple sclerosis.
   PLoS One. 2025;20:e0315501.
   PubMed     Abstract available
   
   
   
9. ZHANG S, Hu W, Tang Y, Chen X, et al
   Identification and validation of key autophagy-related genes in lupus nephritis by bioinformatics and machine learning.
   PLoS One. 2025;20:e0318280.
   PubMed     Abstract available
   
   
   
10. ZHAO YF, Chaw JK, Ang MC, Tew Y, et al
    A safe-enhanced fully closed-loop artificial pancreas controller based on deep reinforcement learning.
    PLoS One. 2025;20:e0317662.
    PubMed     Abstract available
    
    
    
11. IMAN K, Akter L, Rahman MM, Laila K, et al
    Treatment of refractory poly articular course juvenile idiopathic arthritis with tofacitinib: Extended experience from Bangladesh.
    PLoS One. 2025;20:e0312174.
    PubMed     Abstract available
    
    
    
12. JAALKHOROL M, Dashtseren A, Magnaibayar G, Bat-Orgil B, et al
    Factors associated with vitamin D levels in Mongolian patients with multiple sclerosis.
    PLoS One. 2025;20:e0317279.
    PubMed     Abstract available
    
    
    
13. YE W, Ding Y, Li M, Tian Z, et al
    Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database.
    PLoS One. 2025;20:e0317680.
    PubMed     Abstract available
    
    
    
14. JOERNS EK, Ghebranious MA, Adams TN, Makris UE, et al
    Evaluation of comorbidity burden on disease progression and mortality in patients with interstitial pneumonia with autoimmune features: A retrospective cohort study.
    PLoS One. 2025;20:e0316762.
    PubMed     Abstract available
    
    
    
15. DAVE S, Rahi JS, Petrushkin H, Testi I, et al
    UVESCREEN1: A randomised feasibility study of imaging-based uveitis screening for children with juvenile idiopathic arthritis- Study Protocol.
    PLoS One. 2025;20:e0316410.
    PubMed     Abstract available
    
    
    
16. MAMELI C, Valsecchi C, Cereda D, Scarioni S, et al
    Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy.
    PLoS One. 2025;20:e0316340.
    PubMed     Abstract available
    
    
    
17. MCCARTHY EM, Dinneen SF, Byrne M, Morrissey EC, et al
    Perceptions and experiences of young adults and their healthcare team of the D1 Now type 1 diabetes intervention.
    PLoS One. 2025;20:e0316345.
    PubMed     Abstract available
    
    
    
18. COSTA V, Aluan K, Schiavetti I, Bason C, et al
    Study protocol: Exploratory trial of Forza, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.
    PLoS One. 2025;20:e0311214.
    PubMed     Abstract available
    
    
    
19. KHDAIR SI, Al-Khareisha L, Abusara OH, Hammad AM, et al
    HLA-class II genes association with multiple sclerosis: An immunogenetic prediction among multiple sclerosis Jordanian patients.
    PLoS One. 2025;20:e0318824.
    PubMed     Abstract available
    
    
    
20. DE DIOS PEREZ B, Booth V, das Nair R, Evangelou N, et al
    Vocational rehabilitation for people with multiple sclerosis in the national health service of the United Kingdom: A realist evaluation.
    PLoS One. 2025;20:e0319287.
    PubMed     Abstract available
    
    
    
21. TATULASHVILI S, Dreves B, Cosson E, Meyer L, et al
    First validity testing of GluciQuizz, a French self-questionnaire evaluating carb-counting for patients with type 1 diabetes.
    PLoS One. 2025;20:e0318746.
    PubMed     Abstract available
    
    
    
22. CHEN S, Cui X, Chen Y, Guo X, et al
    Biologic therapies for the treatment of large vessel vasculitis: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314566.
    PubMed     Abstract available
    
    
    
23. ISLAM MZ, Zimmerman S, Lindahl A, Weidanz J, et al
    Single-cell RNA-seq reveals disease-specific CD8+ T cell clonal expansion and a high frequency of transcriptionally distinct double-negative T cells in diabetic NOD mice.
    PLoS One. 2025;20:e0317987.
    PubMed     Abstract available
    
    
    
24. SHIMIZU S, Tanaka A, Matsuyama N, Kinoshita F, et al
    Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.
    PLoS One. 2025;20:e0320070.
    PubMed     Abstract available
    
    
    
25. RUSSO JS, Mahoney T, Kokorin K, Reynolds A, et al
    Towards developing brain-computer interfaces for people with Multiple Sclerosis.
    PLoS One. 2025;20:e0319811.
    PubMed     Abstract available
    
    
    
26. ETEMADIFAR M, Shoeib S, Salari M, Etemadifar M, et al
    Gynecologic health of women with multiple sclerosis: An overview on the current status and findings of Pap tests in a low-income setting.
    PLoS One. 2025;20:e0320069.
    PubMed     Abstract available
    
    
    
27. WANG S, Ka M, Wu W
    Does hydroxychloroquine reduce the risk of infection in patients with systemic lupus erythematosus? a systematic review and meta-analysis.
    PLoS One. 2025;20:e0320353.
    PubMed     Abstract available
    
    
    
28. REN Y, Chen W, Lin Y, Wang Z, et al
    Identification of glucocorticoid-related genes in systemic lupus erythematosus using bioinformatics analysis and machine learning.
    PLoS One. 2025;20:e0319737.
    PubMed     Abstract available
    
    
    
29. SALAME G, Hakim V, Dagher C, Daou RM, et al
    Immunotherapy as a treatment for type 1 diabetes mellitus in children and young adults: A comprehensive systematic review and meta-analysis.
    PLoS One. 2025;20:e0321727.
    PubMed     Abstract available
    
    
    
30. GOETTFRIED E, Barket R, Hershman R, Delazer M, et al
    Face exploration, emotion recognition, and emotional enhancement of memory in relapsing-remitting multiple sclerosis.
    PLoS One. 2025;20:e0319967.
    PubMed     Abstract available
    
    
    
31. SU Y, Li X, Wu PD, Zhang YL, et al
    The Association between PTPN22 SNPs and susceptibility to type 1 diabetes: An updated meta-analysis.
    PLoS One. 2025;20:e0321624.
    PubMed     Abstract available
    
    
    
32. SCHLAEGER S, Muhlau M, Gilbert G, Vavasour I, et al
    Sensitivity of multi-parametric quantitative magnetic resonance imaging for multiple sclerosis pathology.
    PLoS One. 2025;20:e0318415.
    PubMed     Abstract available
    
    
    
33. WU Q, Chen Y, Shen M, Cai Y, et al
    Moderate to severe chronic arteriolar lesions is an independent risk factor for adverse renal outcomes in IgA nephropathy.
    PLoS One. 2025;20:e0320635.
    PubMed     Abstract available
    
    
    
34. ZANGENEH Z, Rostamian M, Motamedi H, Alvandi A, et al
    The potential effectiveness of probiotics in reducing multiple sclerosis progression in preclinical and clinical studies: A worldwide systematic review and meta-analysis.
    PLoS One. 2025;20:e0319755.
    PubMed     Abstract available
    
    
    
35. GUTIERREZ-GUTIERREZ G, Gomez-Ballesteros R, Sotoca J, Ares A, et al
    Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol.
    PLoS One. 2025;20:e0322168.
    PubMed     Abstract available
    
    
    
36. YIN J, Hou Y, Wang C, Qin C, et al
    Clinical outcomes of baricitinib in patients with systemic lupus erythematosus: Pooled analysis of SLE-BRAVE-I and SLE-BRAVE-II trials.
    PLoS One. 2025;20:e0320179.
    PubMed     Abstract available
    
    
    
37. HE S, Nie H, Yin X, Zhong Z, et al
    Identification of key extracellular proteins as the potential biomarkers in thyroid eye disease.
    PLoS One. 2025;20:e0322415.
    PubMed     Abstract available
    
    
    
38. MENG H, Wang S, Gu L, Wang Y, et al
    Potential drug targets for Neuromyelitis optica spectrum disorders (NMOSD): A Mendelian randomization analysis.
    PLoS One. 2025;20:e0322098.
    PubMed     Abstract available
    
    
    
39. ALAZWARI A, Tafakori L, Johnstone A, Abdollahian M, et al
    Modeling the number of new cases of childhood type 1 diabetes using Poisson regression and machine learning methods; a case study in Saudi Arabia.
    PLoS One. 2025;20:e0321480.
    PubMed     Abstract available
    
    
    
40. ALMOMANI BA, Elayyan RN, Al-Shatnawi SF
    Type 1 diabetes mellitus in children: Patient reported outcomes.
    PLoS One. 2025;20:e0322882.
    PubMed     Abstract available
    
    
    
41. MCKECHNIE V, Avari P, Eng PC, Unsworth R, et al
    The experiences of high-risk young adults with type 1 diabetes transitioning to real-time continuous glucose monitoring - A thematic analysis.
    PLoS One. 2025;20:e0320702.
    PubMed     Abstract available
    
    
    
42. HERMINE O, Gros L, Tran TA, Loussaief L, et al
    Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease.
    PLoS One. 2025;20:e0322199.
    PubMed     Abstract available
    
    
    
43. MITTAL R, McKenna K, Lemos JRN, Juneja S, et al
    Therapeutic potential of anti-thymocyte globulin in type 1 diabetes: A systematic review.
    PLoS One. 2025;20:e0323642.
    PubMed     Abstract available
    
    
    
44. GUAN X, Liu W, Gao T, Jin W, et al
    Anti-beta2GPI/beta2GPI complex promotes thrombosis by activating the P2Y2/MAPKs pathway to increase human neutrophil peptides.
    PLoS One. 2025;20:e0322447.
    PubMed     Abstract available
    
    
    
45. OMER N, Wilczynski E, Zlotzover S, Helft C, et al
    Validation of a data-driven multicomponent T2 analysis for quantifying myelin content in the cuprizone mouse model of multiple sclerosis.
    PLoS One. 2025;20:e0323614.
    PubMed     Abstract available
    
    
    
46. YOUNG G, Nguyen VS, Howlett-Prieto Q, Abuaf AF, et al
    Validation of retroactively derived T1 relaxation values from 3D T1-weighted images with clinical and MRI measures of disability in multiple sclerosis.
    PLoS One. 2025;20:e0323898.
    PubMed     Abstract available
    
    
    
47. OZTURK HK, Slanar O, Michalickova D
    Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review.
    PLoS One. 2025;20:e0320814.
    PubMed     Abstract available
    
    
    
48. LAI L, Wu C, Li X, Rong Y, et al
    Urinary MCP-1 and VCAM-1 as non-invasive biomarkers for the diagnosis and activity assessment of lupus nephritis.
    PLoS One. 2025;20:e0323334.
    PubMed     Abstract available
    
    
    
49. KRULL F, Hosseini S, Bleyer M, Brenig B, et al
    Findings from transcriptomics and immunohistochemistry indicate an autoimmune disease targeting brainstem inhibitory interneurons in bovine spastic paresis.
    PLoS One. 2025;20:e0324633.
    PubMed     Abstract available
    
    
    
50. MAKHLOUF Y, Ayed HB, Miladi S, Boussaa H, et al
    Effect of biologic treatments on growth in children with juvenile idiopathic arthritis: A systematic review.
    PLoS One. 2025;20:e0324440.
    PubMed     Abstract available
    
    
    
51. RAINA M, Shah R, Hu J, Pember B, et al
    The global health burden of pediatric chronic kidney disease: An analysis of the Global Burden of Disease database from 1990 to 2021.
    PLoS One. 2025;20:e0323257.
    PubMed     Abstract available
    
    
    
52. JARAB AS, Al-Qerem WA, Alqudah S, Alzoubi KH, et al
    Insulin-self administration among individuals with diabetes: Implications for improved practices.
    PLoS One. 2025;20:e0324846.
    PubMed     Abstract available
    
    
    
53. WULLER S, Singer NG, Lewis C, Karlson EW, et al
    Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts.
    PLoS One. 2025;20:e0324513.
    PubMed     Abstract available
    
    
    
54. ANGENETE OW, Haustreis J, Aune LK, Lundestad A, et al
    Children as controls in research; The voice of the volunteer.
    PLoS One. 2025;20:e0325069.
    PubMed     Abstract available
    
    
    
55. JEYABALAN A, Jhaveri KD, Bunke M, Briggs JA, et al
    Clinical study outcomes in IgA nephropathy: A systematic literature review and narrative synthesis.
    PLoS One. 2025;20:e0323530.
    PubMed     Abstract available
    
    
    
56. JIANG W, Peng X, Dong L, Wu L, et al
    Predictors of neuropsychiatric manifestations in pediatric patients with lupus.
    PLoS One. 2025;20:e0325915.
    PubMed     Abstract available
    
    
    
57. BLOIS SL, Cuq BY, Bienzle D
    Lymphocyte immunophenotype in dogs with immune-mediated hematologic disease.
    PLoS One. 2025;20:e0326341.
    PubMed     Abstract available
    
    
    
58. DE DIOS PEREZ B, Kendrick D, das Nair R, Evangelou N, et al
    Optimising access to vocational rehabilitation through multiple sclerosis charities: Protocol for a feasibility randomised controlled trial.
    PLoS One. 2025;20:e0325570.
    PubMed     Abstract available
    
    
    
59. BOZZI S, Umarje S, Hawaldar K, Tyma J, et al
    Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016-2023.
    PLoS One. 2025;20:e0323843.
    PubMed     Abstract available
    
    
    
60. MOHAMED YM, Mancera J, Brandenberg A, Fischli S, et al
    Personalized machine learning models for noninvasive hypoglycemia detection in people with type 1 diabetes using a smartwatch: Insights into feature importance during waking and sleeping times.
    PLoS One. 2025;20:e0325956.
    PubMed     Abstract available
    
    
    
61. MARTIN-AVILA J, Rodriguez-Jimenez E, Valero-Moreno S, Gil-Gomez JA, et al
    Intervention through an intelligent technological platform for socio-emotional development and health promotion in adolescents with Type 1 Diabetes Mellitus (emoTICare): A study protocol for randomized controlled trial.
    PLoS One. 2025;20:e0325763.
    PubMed     Abstract available
    
    
    
62. CARAZO A, Paclikova M, Fadraersada J, Alva-Gallegos R, et al
    Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants.
    PLoS One. 2025;20:e0326580.
    PubMed     Abstract available
    
    
    
63. TAKAHASHI K, Takeishi C, Tsutsumi C, Nakao T, et al
    Exploring the relationship between self-care agency and quality of life in adults with diabetes: A cross-sectional study.
    PLoS One. 2025;20:e0326783.
    PubMed     Abstract available
    
    
    
64. WANG K, Xu P, Lu J, Ji X, et al
    Circadian rhythm genes and immune cell infiltration in myasthenia gravis: A comprehensive analysis.
    PLoS One. 2025;20:e0327829.
    PubMed     Abstract available
    
    
    January 2024
65. XUE H, Zeng L, He H, Xu D, et al
    Effects of acupuncture treatment for myasthenia gravis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0291685.
    PubMed     Abstract available
    
    
    
66. EKMAN L, Dahlin LB, Andersson GS, Lindholm E, et al
    Diagnostic contribution of multi-frequency vibrometry to detection of peripheral neuropathy in type 1 diabetes mellitus compared with nerve conduction studies.
    PLoS One. 2024;19:e0296661.
    PubMed     Abstract available
    
    
    
67. MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
    Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
    PLoS One. 2024;19:e0290879.
    PubMed     Abstract available
    
    
    
68. DASGUPTA SK, Gollamudi J, Rivera S, Poche RA, et al
    beta2-glycoprotein I promotes the clearance of circulating mitochondria.
    PLoS One. 2024;19:e0293304.
    PubMed     Abstract available
    
    
    
69. TOLF A, Gauffin H, Burman J, Landtblom AM, et al
    Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
    PLoS One. 2024;19:e0297573.
    PubMed     Abstract available
    
    
    
70. YANG H, Chen Z, Huang J, Li S, et al
    AWD-stacking: An enhanced ensemble learning model for predicting glucose levels.
    PLoS One. 2024;19:e0291594.
    PubMed     Abstract available
    
    
    
71. DADVAR A, Jameie M, Azizmohammad Looha M, Parsaei M, et al
    Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
    PLoS One. 2024;19:e0297235.
    PubMed     Abstract available
    
    
    
72. JAKA S, Singh S, Vashist S, Pokhrel S, et al
    Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
    PLoS One. 2024;19:e0296870.
    PubMed     Abstract available
    
    
    
73. MITTAL R, McKenna K, Keith G, Lemos JRN, et al
    A systematic review of the association of Type I diabetes with sensorineural hearing loss.
    PLoS One. 2024;19:e0298457.
    PubMed     Abstract available
    
    
    
74. SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
    The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0297510.
    PubMed     Abstract available
    
    
    
75. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    PubMed     Abstract available
    
    
    
76. LIU X, Xue J, Li T, Wu Q, et al
    Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
    PLoS One. 2024;19:e0298269.
    PubMed     Abstract available
    
    
    
77. SMUDJA M, Milenkovic T, Minakovic I, Zdravkovic V, et al
    Self-care activities in pediatric patients with type 1 diabetes mellitus.
    PLoS One. 2024;19:e0300055.
    PubMed     Abstract available
    
    
    
78. TRAN TT, Nguyen TN, Dauvilliers Y, Liblau R, et al
    Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening.
    PLoS One. 2024;19:e0297625.
    PubMed     Abstract available
    
    
    
79. JOZEF M, Locatelli I, Brecl Jakob G, Savsek L, et al
    Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.
    PLoS One. 2024;19:e0294116.
    PubMed     Abstract available
    
    
    
80. LIU P, Luo J, Zhao L, Fu Q, et al
    Causal relationship between several autoimmune diseases and renal malignancies: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297861.
    PubMed     Abstract available
    
    
    
81. FLOYD L, Dhaygude A, Mitra S, Rowland C, et al
    Developing a disease-specific patient reported outcome measure to enhance understanding of the lived experiences of ANCA associated vasculitis: A protocol paper.
    PLoS One. 2024;19:e0298796.
    PubMed     Abstract available
    
    
    
82. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    PubMed     Abstract available
    
    
    
83. CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
    The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
    PLoS One. 2024;19:e0283060.
    PubMed     Abstract available
    
    
    
84. LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
    Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
    PLoS One. 2024;19:e0300914.
    PubMed     Abstract available
    
    
    
85. BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
    Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
    PLoS One. 2024;19:e0300708.
    PubMed     Abstract available
    
    
    
86. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    PubMed     Abstract available
    
    
    
87. ESIASON DC, Ciesinski N, Nurse CN, Erler W, et al
    The psychological burden of NMOSD - a mixed method study of patients and caregivers.
    PLoS One. 2024;19:e0300777.
    PubMed     Abstract available
    
    
    
88. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    PubMed     Abstract available
    
    
    
89. MA J, Xing J, Zhang Y, Liu G, et al
    Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0298732.
    PubMed     Abstract available
    
    
    
90. JANSSENS N, Van Wilder L, Van Hecke A, Van Hoorenbeeck K, et al
    COCCOS study: Developing a transition program for adolescents with chronic conditions using Experience-Based Co-Design. A study protocol.
    PLoS One. 2024;19:e0298571.
    PubMed     Abstract available
    
    
    
91. MEDINA-RAMIREZ SA, Soriano-Moreno DR, Tuco KG, Castro-Diaz SD, et al
    Prevalence and incidence of diabetic retinopathy in patients with diabetes of Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0296998.
    PubMed     Abstract available
    
    
    
92. YAGHOOBPOOR S, Fathi M, Vakili K, Sayehmiri F, et al
    Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297091.
    PubMed     Abstract available
    
    
    
93. LOMER NB, Asalemi KA, Saberi A, Sarlak K, et al
    Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
    PLoS One. 2024;19:e0300415.
    PubMed     Abstract available
    
    
    
94. LI H, Huntington S, Gross C, Wang SY, et al
    Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease.
    PLoS One. 2024;19:e0300789.
    PubMed     Abstract available
    
    
    
95. DE RIDDER F, Braspenning R, Ordonez JS, Klarenbeek G, et al
    Early feasibility study with an implantable near-infrared spectroscopy sensor for glucose, ketones, lactate and ethanol.
    PLoS One. 2024;19:e0301041.
    PubMed     Abstract available
    
    
    
96. SCAGNELLATO L, Cozzi G, Prosepe I, Lorenzin M, et al
    Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience.
    PLoS One. 2024;19:e0298679.
    PubMed     Abstract available
    
    
    
97. SVENSSON AK, Dahlin LB, Rydberg M, Perez R, et al
    Surgery for carpal tunnel syndrome in patients with and without diabetes-Is there a difference in the frequency of surgical procedures?
    PLoS One. 2024;19:e0302219.
    PubMed     Abstract available
    
    
    
98. ZHOU K, Zhou J, Zhou L, Xue J, et al
    Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
    PLoS One. 2024;19:e0302100.
    PubMed     Abstract available
    
    
    
99. UEDA H, Joh K, Ueda Y, Marumoto H, et al
    Accelerated involution of germinal center in palatine tonsils in IgA nephropathy.
    PLoS One. 2024;19:e0301853.
    PubMed     Abstract available
    
    
    
100. LEE YH, Song GG
     Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
     PLoS One. 2024;19:e0303665.
     PubMed     Abstract available
     
     
     
101. ZHAI Y, Tian H, Zhang W, Sun S, et al
     Genome-wide analysis of long noncoding RNAs as cis-acting regulators of transcription factor-encoding genes in IgA nephropathy.
     PLoS One. 2024;19:e0304301.
     PubMed     Abstract available
     
     
     
102. CREMER T, Hoelen H, van de Weijer ML, Janssen GM, et al
     Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2.
     PLoS One. 2024;19:e0287877.
     PubMed     Abstract available
     
     
     
103. COBB J, Rawson J, Gonzalez N, Orr C, et al
     Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
     PLoS One. 2024;19:e0303863.
     PubMed     Abstract available
     
     
     
104. REBALKA IA, Noguchi KS, Bulyovsky KR, Badour MI, et al
     Targeting skeletal muscle health with exercise in people with type 1 diabetes: A protocol for HOMET1D, a prospective observational trial with matched controls.
     PLoS One. 2024;19:e0303448.
     PubMed     Abstract available
     
     
     
105. JEONG C, Baek H, Bae J, Hwang N, et al
     Gut microbiome in the Graves' disease: Comparison before and after anti-thyroid drug treatment.
     PLoS One. 2024;19:e0300678.
     PubMed     Abstract available
     
     
     
106. HARRISON DM, Allette YM, Zeng Y, Cohen A, et al
     Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
     PLoS One. 2024;19:e0300298.
     PubMed     Abstract available
     
     
     
107. DUAN P, Tian S
     Mendelian randomization analyses reveal no genetic causal effects of major adipokines on systemic lupus erythematosus.
     PLoS One. 2024;19:e0301699.
     PubMed     Abstract available
     
     
     
108. EKELUND C, Dereke J, Nilsson C, Landin-Olsson M, et al
     Are soluble E-selectin, ICAM-1, and VCAM-1 potential predictors for the development of diabetic retinopathy in young adults, 15-34 years of age? A Swedish prospective cohort study.
     PLoS One. 2024;19:e0304173.
     PubMed     Abstract available
     
     
     
109. BALDASSO BD, Raza SZ, Islam SS, Burry IB, et al
     Disrupted hemodynamic response within dorsolateral prefrontal cortex during cognitive tasks among people with multiple sclerosis-related fatigue.
     PLoS One. 2024;19:e0303211.
     PubMed     Abstract available
     
     
     
110. BAXTER F, Baillie N, Dover A, Stimson RH, et al
     A cross-sectional questionnaire study: Impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemia.
     PLoS One. 2024;19:e0297601.
     PubMed     Abstract available
     
     
     
111. STEFANOVIC M, Jovanovic I, Zivkovic M, Stankovic A, et al
     Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.
     PLoS One. 2024;19:e0305042.
     PubMed     Abstract available
     
     
     
112. ALMUTAIRI FF
     The feasibility of point shear wave elastography (pSWE) in the assessment of pancreas stiffness in diabetic patients and healthy volunteers.
     PLoS One. 2024;19:e0303098.
     PubMed     Abstract available
     
     
     
113. CHI G, Pei J, Li X
     Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
     PLoS One. 2024;19:e0305220.
     PubMed     Abstract available
     
     
     
114. SERATA EL, Noonan EJ, Petersen KH
     Barriers to USMLE Step-1 accommodations: Students with Type 1 Diabetes.
     PLoS One. 2024;19:e0304784.
     PubMed     Abstract available
     
     
     
115. HE L, He W
     Clinicopathologic features and outcomes of bilateral lacrimal gland lesions.
     PLoS One. 2024;19:e0305717.
     PubMed     Abstract available
     
     
     
116. GEBREMESKEL GG, Haile TG, Gebrewahd GT, Hailay A, et al
     Effectiveness of non-pharmacological therapies for chronic pain in people with autoimmune diseases in Africa: A protocol for a systematic review and meta-analysis.
     PLoS One. 2024;19:e0306564.
     PubMed     Abstract available
     
     
     
117. LI Z, Jia B, Guo Z, Zhang K, et al
     Therapeutic potential of salidroside in type I diabetic erectile dysfunction: Attenuation of oxidative stress and apoptosis via the Nrf2/HO-1 pathway.
     PLoS One. 2024;19:e0306926.
     PubMed     Abstract available
     
     
     
118. PIKULIN S, Yehezkel I, Moskovitch R
     Enhanced blood glucose levels prediction with a smartwatch.
     PLoS One. 2024;19:e0307136.
     PubMed     Abstract available
     
     
     
119. SUMIMOTO H, Noda S, Koide H, Douke Y, et al
     Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.
     PLoS One. 2024;19:e0306995.
     PubMed     Abstract available
     
     
     
120. CAMPANIONI S, Veiga C, Prieto-Gonzalez JM, Gonzalez-Novoa JA, et al
     Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.
     PLoS One. 2024;19:e0306999.
     PubMed     Abstract available
     
     
     
121. YAMADA K, Tanabe A, Hashimoto M, Ohsugi M, et al
     A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis.
     PLoS One. 2024;19:e0308076.
     PubMed     Abstract available
     
     
     
122. WANG YY, Ying HM, Tian F, Qian XL, et al
     Three months use of Hybrid Closed Loop Systems improves glycated hemoglobin levels in adolescents and children with type 1 diabetes: A meta-analysis.
     PLoS One. 2024;19:e0308202.
     PubMed     Abstract available
     
     
     
123. KIM N, Kim S, Choi JR, Park Y, et al
     Evaluation of autoimmune liver disease antibodies in hepatitis patients.
     PLoS One. 2024;19:e0307285.
     PubMed     Abstract available
     
     
     
124. LI B, Zhang L, Li Q, Zhang J, et al
     Multiple sclerosis and abnormal spermatozoa: A bidirectional two-sample mendelian randomization study.
     PLoS One. 2024;19:e0308815.
     PubMed     Abstract available
     
     
     
125. LEE MJ, Verma R, Hamilton BE, Pettersson D, et al
     The utility of orbital imaging in the evaluation of orbital disease.
     PLoS One. 2024;19:e0308528.
     PubMed     Abstract available
     
     
     
126. CHAIPRASERT A, Han P, Laomettachit T, Ruengjitchatchawalya M, et al
     Network analysis retrieving bioactive compounds from Spirulina (Arthrospira platensis) and their targets related to systemic lupus erythematosus.
     PLoS One. 2024;19:e0309303.
     PubMed     Abstract available
     
     
     
127. KAKUCS Z, Illes Z, Hayden Z, Berki T, et al
     Osteopontin predicts late-time salience network-related functional connectivity in multiple sclerosis.
     PLoS One. 2024;19:e0309563.
     PubMed     Abstract available
     
     
     
128. WEISE S, Du Y, Heidemann C, Baumert J, et al
     Diabetes self-management education programs: Results from a nationwide population-based study on characteristics of participants, rating of programs and reasons for non-participation.
     PLoS One. 2024;19:e0310338.
     PubMed     Abstract available
     
     
     
129. D'ALESSANDRO M, Cameli P, Cotton CV, Lamb JA, et al
     Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease.
     PLoS One. 2024;19:e0311357.
     PubMed     Abstract available
     
     
     
130. CAMBOULIVE L, Grandhomme F, Martin Silva N, Khoy K, et al
     Clinical impact of ceruloplasmin levels at ANCA-associated vasculitis diagnosis.
     PLoS One. 2024;19:e0311678.
     PubMed     Abstract available
     
     
     
131. MAGEAU A, Geradin C, Sallah K, Papo T, et al
     Risk of systemic lupus erythematosus flare after COVID-19 hospitalization: A matched cohort study.
     PLoS One. 2024;19:e0309316.
     PubMed     Abstract available
     
     
     
132. BUIANOVA A, Yukina M, Cheranev V, Suchalko O, et al
     Trio-based exome sequencing and high-resolution HLA typing in families of patients with autoimmune adrenal insufficiency and autoimmune polyglandular syndrome.
     PLoS One. 2024;19:e0312335.
     PubMed     Abstract available
     
     
     
133. SOKRATOUS D, Charalambous CC, Zamba-Papanicolaou E, Michailidou K, et al
     A 12-week in-phase bilateral upper limb exercise protocol promoted neuroplastic and clinical changes in people with relapsing remitting multiple sclerosis: A registered report randomized single-case concurrent multiple baseline study.
     PLoS One. 2024;19:e0299611.
     PubMed     Abstract available
     
     
     
134. SABOYA-GALINDO P, Mejia-Salgado G, Cifuentes-Gonzalez C, Rodriguez-Rodriguez CA, et al
     Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0307455.
     PubMed     Abstract available
     
     
     
135. KOVACEVIC S, Zdravkovic V, Blagojevic J, Djordjevic S, et al
     Association of variants in AGTR1, ACE, MTHFR genes with microalbuminuria and risk factors for the onset of diabetic nephropathy in adolescents with type 1 diabetes in the population of Serbia.
     PLoS One. 2024;19:e0312489.
     PubMed     Abstract available
     
     
     
136. GIRAUD E, Fiette L, Melanitou E
     Type 1 diabetes and parasite infection: An exploratory study in NOD mice.
     PLoS One. 2024;19:e0308868.
     PubMed     Abstract available
     
     
     
137. TISELL A, Soderberg K, Link Y, Lundberg P, et al
     Diffuse white matter pathology in multiple sclerosis during treatment with dimethyl fumarate-An observational study of changes in normal-appearing white matter using proton magnetic resonance spectroscopy.
     PLoS One. 2024;19:e0309547.
     PubMed     Abstract available
     
     
     
138. FABER W, Stillebroer AB
     Addressing bladder and bowel challenges in dutch multiple sclerosis patients: Symptom prevalence and patient referral pathways.
     PLoS One. 2024;19:e0310691.
     PubMed     Abstract available
     
     
     
139. NAFARI A, Vaheb S, Afshari-Safavi A, Ravankhah Z, et al
     Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran.
     PLoS One. 2024;19:e0312707.
     PubMed     Abstract available
     
     
     
140. LI Y, Kong D, Ding Y, Wang J, et al
     The potential impact of COVID-19 vaccination on patients with immune thrombocytopenic purpura: A protocol for systematic review and meta-analysis.
     PLoS One. 2024;19:e0308546.
     PubMed     Abstract available
     
     
     
141. IAQUINTO S, Ineichen BV, Salmen A, Kuhle J, et al
     Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approach.
     PLoS One. 2024;19:e0312486.
     PubMed     Abstract available
     
     
     
142. DE LA CRUZ A, Garces M, Larios E, Madera-Salcedo IK, et al
     Immune complex deposition promotes NK cell accumulation in the kidney.
     PLoS One. 2024;19:e0312141.
     PubMed     Abstract available
     
     
     
143. MARIC GD, Pekmezovic TD, Tamas OS, Veselinovic ND, et al
     Investigation of differences between chronological and vascular age in persons with multiple sclerosis.
     PLoS One. 2024;19:e0311117.
     PubMed     Abstract available
     
     
     
144. RIVERA-FRANCO N, Lopez-Alvarez D, Castillo A, Aristizabal E, et al
     Genomic variability in Zika virus in GBS cases in Colombia.
     PLoS One. 2024;19:e0313545.
     PubMed     Abstract available
     
     
     
145. NAJMI EA, Mirzaasgari Z, Motamed MR, Aslani A, et al
     Carotid intima-media thickness and risk of atherosclerosis in multiple sclerosis: A cross-sectional study.
     PLoS One. 2024;19:e0314031.
     PubMed     Abstract available
     
     
     
146. SALEEM O, Iqbal J
     Blood-glucose regulator design for diabetics based on LQIR-driven Sliding-Mode-Controller with self-adaptive reaching law.
     PLoS One. 2024;19:e0314479.
     PubMed     Abstract available
     
     
     
147. ZURRER WE, Cannon AE, Ewing E, Bruschweiler D, et al
     STEED: A data mining tool for automated extraction of experimental parameters and risk of bias items from in vivo publications.
     PLoS One. 2024;19:e0311358.
     PubMed     Abstract available
     
     
     
148. MIRMOSAYYEB O, Yazdan Panah M, Mokary Y, Mohammadi M, et al
     Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0312421.
     PubMed     Abstract available
     
     
     
149. CHEIBCHALARD T, Leelahavanichkul A, Chatthanathon P, Klankeo P, et al
     Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
     PLoS One. 2024;19:e0314662.
     PubMed     Abstract available
     
     
     
150. TSUNODA R, Kume K, Kagawa R, Sanuki M, et al
     Machine-learning-based identification of patients with IgA nephropathy using a computerized medical billing database.
     PLoS One. 2024;19:e0312915.
     PubMed     Abstract available
     
     
     
151. RASOULI S, Dakkali MS, Ghazvini A, Azarbad R, et al
     Predictive model for converting optic neuritis to multiple sclerosis; decision tree in focus.
     PLoS One. 2024;19:e0309702.
     PubMed     Abstract available
     
     
     
152. DESCHAMPS N, Nacher M, Preux PM, Takam V, et al
     Pattern, causes and functional outcome of peripheral neuropathies in the Amazon region.
     PLoS One. 2024;19:e0315760.
     PubMed     Abstract available
     
     
     
153. SHRIWASH N, Aiman A, Singh P, Basir SF, et al
     Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
     PLoS One. 2024;19:e0314428.
     PubMed     Abstract available
     
     
     
154. LEE JY, Lee SB, Yang SW, Paik JS, et al
     Linsitinib inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion by suppressing PI3K/Akt and ERK pathway in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
     PLoS One. 2024;19:e0311093.
     PubMed     Abstract available
     
     
     
155. KOOSHKI A, Farmani R, Amirabadizadeh A, Mehrpour O, et al
     Essential and toxic metal concentrations in biological samples of multiple sclerosis patients: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0313851.
     PubMed     Abstract available
     
     
     
156. BIGDELI A, Ghaderi-Zefrehei M, Lesch BJ, Behmanesh M, et al
     Bioinformatics analysis of myelin-microbe interactions suggests multiple types of molecular mimicry in the pathogenesis of multiple sclerosis.
     PLoS One. 2024;19:e0308817.
     PubMed     Abstract available
     
     
     January 2023
157. TEKIN H, Frobert O, Graesli AR, Kindberg J, et al
     Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
     PLoS One. 2023;18:e0291063.
     PubMed     Abstract available
     
     
     
158. LIN DY, Andreotti AH
     Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib.
     PLoS One. 2023;18:e0290872.
     PubMed     Abstract available
     
     
     
159. MONSTED MO, Holm LJ, Buschard K, Haupt-Jorgensen M, et al
     Failure to replicate the diabetes alleviating effect of a maternal gluten-free diet in non-obese diabetic mice.
     PLoS One. 2023;18:e0289258.
     PubMed     Abstract available
     
     
     
160. HOWLAND S, Huber J, Aicken C
     Designing a brief and simple intervention to help young people with type 1 diabetes to live well: Protocol for developing a novel intervention with participation from young people.
     PLoS One. 2023;18:e0285300.
     PubMed     Abstract available
     
     
     
161. SIKORSKI P, Li Y, Cheema M, Wolfe GI, et al
     Serum metabolomics of treatment response in myasthenia gravis.
     PLoS One. 2023;18:e0287654.
     PubMed     Abstract available
     
     
     
162. POLICK CS, Ploutz-Snyder R, Braley TJ, Connell CM, et al
     Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.
     PLoS One. 2023;18:e0292233.
     PubMed     Abstract available
     
     
     
163. PHAM HN, Pham L, Sato K
     Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis.
     PLoS One. 2023;18:e0292998.
     PubMed     Abstract available
     
     
     
164. PARK SS, Mai M, Ploszaj M, Cai H, et al
     Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice.
     PLoS One. 2023;18:e0291948.
     PubMed     Abstract available
     
     
     
165. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
     A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
     PLoS One. 2023;18:e0294193.
     PubMed     Abstract available
     
     
     
166. KRAKENES T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, et al
     The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
     PLoS One. 2023;18:e0293908.
     PubMed     Abstract available
     
     
     
167. ABIDOV M, Sokolova K, Danilova I, Baykenova M, et al
     Hepatic insulin synthesis increases in rat models of diabetes mellitus type 1 and 2 differently.
     PLoS One. 2023;18:e0294432.
     PubMed     Abstract available
     
     
     
168. CHENG CW, Fang WF, Lin JD
     Associations of serum keratin 1 with thyroid function and immunity in Graves' disease.
     PLoS One. 2023;18:e0289345.
     PubMed     Abstract available
     
     
     
169. SUZUKI K, Iwata D, Namba K, Hase K, et al
     Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis.
     PLoS One. 2023;18:e0294745.
     PubMed     Abstract available
     
     
     
170. WALLE M, Arkew M, Asmerom H, Tesfaye A, et al
     The diagnostic accuracy of mean platelet volume in differentiating immune thrombocytopenic purpura from hypo-productive thrombocytopenia: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0295011.
     PubMed     Abstract available
     
     
     
171. ZHOU Q, Xiong Z, Yang D, Xiong C, et al
     The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0295135.
     PubMed     Abstract available
     
     
     
172. HARVENGT AA, Polle OG, Martin M, van Maanen A, et al
     Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetes.
     PLoS One. 2023;18:e0294982.
     PubMed     Abstract available
     
     
     
173. TRENTIN-SONODA M, Cheff V, Gutsol A, Hebert RL, et al
     Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes.
     PLoS One. 2023;18:e0295284.
     PubMed     Abstract available
     
     
     
174. LORD SM, Bahnson HT, Greenbaum CJ, Liljenquist DR, et al
     Testing a new platform to screen disease-modifying therapy in type 1 diabetes.
     PLoS One. 2023;18:e0293268.
     PubMed     Abstract available
     
     
     
175. FALLAH M, Najafi A, Balighi K, Daneshpazhooh M, et al
     Association of alternative healthy eating index and severity of pemphigus vulgaris: A cross-sectional study.
     PLoS One. 2023;18:e0295026.
     PubMed     Abstract available
     
     
     
176. ABDULLAHI AS, Suliman A, Khan MA, Khair H, et al
     Temporal trends of hemoglobin among pregnant women: The Mutaba'ah study.
     PLoS One. 2023;18:e0295549.
     PubMed     Abstract available
     
     
     
177. WILF-YARKONI A, Feldmann K, Rubarth K, Dorsch EM, et al
     Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
     PLoS One. 2023;18:e0288366.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.